CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series

Ruf, Stephanie; Hebart, Holger; Hjalgrim, Lisa Lyngsie; Kabickova, Edita; Lang, Peter; Steinbach, Daniel; Schwabe, Georg C.; Woessmann, Wilhelm

dc.contributor.author	Lang, Peter
dc.date.accessioned	2019-09-24T13:17:09Z
dc.date.available	2019-09-24T13:17:09Z
dc.date.issued	2018
dc.identifier.issn	1545-5017
dc.identifier.uri	http://hdl.handle.net/10900/93248
dc.language.iso	en	en
dc.publisher	Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1002/pbc.27003
dc.subject.ddc	610	de_DE
dc.title	CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_02464
utue.personen.roh	Ruf, Stephanie
utue.personen.roh	Hebart, Holger
utue.personen.roh	Hjalgrim, Lisa Lyngsie
utue.personen.roh	Kabickova, Edita
utue.personen.roh	Lang, Peter
utue.personen.roh	Steinbach, Daniel
utue.personen.roh	Schwabe, Georg C.
utue.personen.roh	Woessmann, Wilhelm
dcterms.isPartOf.ZSTitelID	Pediatric Blood & Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article e27003	de_DE
dcterms.isPartOf.ZS-Volume	65	de_DE
utue.fakultaet	04 Medizinische Fakultät